Addentax Reports Advanced Talks To Acquire Partial Stake In Shanghai Bao Pharmaceutical; Financial Terms Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
Addentax is in advanced talks to acquire a partial stake in Shanghai Bao Pharmaceutical from its Chairman and CEO, Mr. Hong Zhida. Bao Pharma has 74 patents and is making progress on its key pipelines.
June 15, 2023 | 12:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Addentax is in advanced talks to acquire a partial stake in Shanghai Bao Pharmaceutical, which has 74 patents and is making progress on its key pipelines.
The acquisition of a partial stake in Bao Pharma could provide Addentax with access to Bao Pharma's patents and pipeline progress, potentially leading to growth opportunities. This news is directly related to Addentax and could have a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100